📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

ß2-spectrin (SPTBN1) as a therapeutic target for diet-induced liver disease and preventing cancer development. (2021)

First Author: Rao S

Attributed to: ADIPOSE TISSUE DYSFUNCTION AND LIPOTOXICITY funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.abk2267

PubMed Identifier: 34910547

Publication URI: http://europepmc.org/abstract/MED/34910547

Type: Journal Article/Review

Volume: 13

Parent Publication: Science translational medicine

Issue: 624

ISSN: 1946-6234